![N-[2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N'-(5-methyl-3-isoxazolyl)urea structure, CAS 475108-18-0](/structures/60000/57338_1_475108_18_0.png)
CAS Number475108-18-0
SynonymsAV951; AV-951; N-(2-chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)urea; Tivozanib; KRN-951; 1-{2-Chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl}-3-(5-methyl-1,2-oxazol-3-yl)urea
Molecular FormulaC22H19ClN4O5
Molecular Weight454.86
Purity≥98 (HPLC)%
Density1.4±0.1 g/cm3
Boiling Point550.4±50.0 °C at 760 mmHg
Appearancepowder
| Chemical & Physical Properties | |
|---|---|
| CAS Number | 475108-18-0 |
| Catalog No. | 2A-9057338 |
| Chinese Name | 替沃扎尼 |
| Synonyms | AV951; AV-951; N-(2-chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)urea; Tivozanib; KRN-951; 1-{2-Chloro-4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl}-3-(5-methyl-1,2-oxazol-3-yl)urea |
| Molecular Formula | C22H19ClN4O5 |
| Molecular Weight | 454.86 |
| Purity | ≥98 (HPLC) |
| Density | 1.4±0.1 g/cm3 |
| Boiling Point | 550.4±50.0 °C at 760 mmHg |
| Appearance | powder |
| Storage Condition | -20°C |
| Application | Tivozanib (AV-951; KRN951) is a potent and selective VEGFR 1/2/3 inhibitor with IC50 values of 0.21, 0.16, and 0.24 nM respectively. |
| MDL Number | MFCD15146788 |
| SMILES | O=C(NC1=C(Cl)C=C(C=C1)OC2=C3C=C(C(OC)=CC3=NC=C2)OC)NC4=NOC(C)=C4 |
| InChI | 1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28) |
| InChI Key | SPMVMDHWKHCIDT-UHFFFAOYSA-N |
| NACRES Code | NA.77 |
| UNSPSC | 12352200 |
| MSDS | msds/57338_1_475108_18_0.pdf |
| Transport Info | Product name: Tivozanib (AV-951) |
| Related Products in Heterocyclic Building Blocks | ||
|---|---|---|
| 5-(Trifluoromethyl)-1H-indole-3-carboxaldehyde | 468718-16-3 | 2A-9057313 |
| tert-Butyl 3-(hydroxymethyl)morpholine-4-carboxylate | 473923-56-7 | 2A-9057324 |
| Pyrazolo[1,5-a]pyridine-7-carboxylic acid | 474432-62-7 | 2A-9057328 |
| 6-Bromo-4-quinazolinecarboxylic acid ammonium salt | 474710-80-0 | 2A-9057332 |
| 3-Aminomethylmorpholine-4-carboxylic acid tert-butyl ester | 475106-18-4 | 2A-9057337 |
| 2-(2-Difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine | 475110-96-4 | 2A-9057339 |
| 4-(4-Chloro-6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazin-2-yl)morpholine | 475111-38-7 | 2A-9057340 |
| 2,3-Dihydro-5-mercapto-3-oxo-4-isothiazolecarboxylic acid sodium salt (1:1) | 475112-25-5 | 2A-9057341 |
| Spiro[furo[3,4-c]pyridine-3(1H),4'-piperidin]-1-one hydrochloride | 475152-16-0 | 2A-9057342 |
| Spiro[furo[3,4-b]pyridine-5(7H),4'-piperidin]-7-one hydrochloride | 475152-31-9 | 2A-9057344 |
| Browse all Heterocyclic Building Blocks products » | ||
Phone:
630-322-8886
630-322-8887
Email:
Office Locations:
Chicago, IL, USA
San Francisco, CA, USA